May 8, 2018 – Jerusalem – Yissum, The Technology Transfer Company of The Hebrew University of Jerusalem, in collaboration with its seed investment fund AgrInnovation, today announced the launch of HUGrow, a new food and ag-tech accelerator...
JERUSALEM, ISRAEL – Future Meat Technologies has announced a $2.2 million seed investment round co-led by Tyson Ventures, the venture capital arm of Tyson Foods. Tyson Foods is a Fortune 100 company, and one of the world’s largest food...
Jerusalem, Israel, February 6, 2018 – Merck, a leading science and technology company, today inaugurated a new technology innovation laboratory at its subsidiary Qlight Nanotech in Jerusalem, hosted on the Hebrew University’s Edmund J. Safra...
NewStem, introduces a novel technology for predicting resistance to chemotherapy treatments. The Company is developing a diagnostic kit based on the pioneering research of Professor Nissim Benvenisty, the Azrieli Center for Stem Cells and Genetic...
Therapix Biosciences Ltd. (NASDAQ, TASE: TRPX), a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based drugs, today announced that it has signed a sublicense agreement for Yissum Research...
Clinical data showed superior efficacy & similar safety of MM-II vs. standard of care (hyaluronic acid) for treatment of pain in osteoarthritis
Sun Pharma to fund further development of MM-II including completion of Phase 2 and Phase 3 clinical...
Revolutionary new technology gives cannabinoids unparalleled access to bloodstream.
Commercial launch by Ananada Scientific of HYGIA Nutrients Brand took place at the Marijuana Business Conference in Las Vegas.
Yissum Research Development Company of the Hebrew University of Jerusalem, the technology-transfer company of the Hebrew University, announced today that Agrinnovation, an investment fund focused on agricultural inventions, has entered into an...
Yissum Research Development Company Ltd., the technology transfer arm of the Hebrew University of Jerusalem, today announced that RenewSense was selected to enter Brainnovation, Israel’s Brain Technologies accelerator.
RenewSenses, based on...
Yissum announced that it has signed a non-exclusive worldwide licensing agreement and a consulting agreement with Lightricks for the development and commercialization of an imaging technology that improves digital image processing. The...
Non-invasive diagnostic test realizes the potential of circulating DNA for detection of multiple diseases
The novel technology was developed by Yinon Ben-Neriah, MD, PhD, Blumenthal Professor of Cancer Research, Lautenberg Center for Immunology, Hebrew University-Hadassah Medical School, with generous support by AMRF (The Dr. Miriam...